HBV-IN-16

CAT: 0804-HY-144047Size: 1 EachDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-144047Size:1 Each

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

HBV-IN-16 is a potent inhibitor of covalently closed circular DNA (cccDNA) . cccDNA serves as the template for viral RNA transcription and subsequent viral DNA generation. HBV-IN-16 is a quinoline derivative. HBV-IN-16 has the potential for the research of HBV infection (extracted from patent WO2019121357A1, compound 1) [1].

CAS Number

2355225-38-4

UNSPSC

12352005

Target

DNA/RNA Synthesis; HBV

Type

Reference compound

Related Pathways

Anti-infection; Cell Cycle/DNA Damage

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/hbv-in-16.html

Solubility

10 mM in DMSO

Smiles

ClC1=CC=CC2=C1N=C(C3=CC=C(C=C3)OCCO[C@H]4C[C@H](C4)C(O)=O)C=C2

Molecular Formula

C22H20ClNO4

Molecular Weight

397.85

References & Citations

[1] Song Feng, et al. Novel quinoline compounds for the treatment and prophylaxis of hepatitis b virus disease. Patent WO2019121357A1.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Related Products

Catalog	Name
HY-146395	HBV-IN-23
HY-149435	HBV-IN-36
HY-149815	HBV-IN-33
HY-148780	HBV-IN-29
HY-146394	HBV-IN-22
HY-148781	HBV-IN-30
HY-145050	HBV-IN-7
HY-145049	HBV-IN-6
HY-162795	HBV-IN-47
HY-177378	HBV-IN-53

Alternative Products

Catalog	Name
GTR19186634-01	HBV-IN-16
MBS485193-01	HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa
ant-150	HBV
P525235	HBV-C Protein (C-His, HBV)
LV1601	HBV(+) and HBV(-) noncancerous liver tissue array
BA1849-10	HBV-IN-37
FSD89784-01	HBV-IN-4
601090020	Truenat™ HBV
T209597-01	HBV-IN-45
T63795-01	HBV-IN-6

HBV-IN-16

Related Products

Alternative Products

Popular Products